English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Nanjing Redsun: glufosinate-ammonium project to be put into production and capacity of Diquat Dichloride to reach 60,000t/a in 2022qrcode

Dec. 7, 2021

Favorites Print
Forward
Dec. 7, 2021

Recently, Nanjing Redsun Co., Ltd. (Nanjing Redsun) revealed that it has been actively promoting the construction of its new Glufosinate-ammonium project and planned to put it into production in 2022. The company will conduct trial production in accordance with relevant industry requirements. Besides, it also planned to build a 15,000 t/a Diquat Dichloride project, increasing its Diquat Dichloride production capacity to 60,000 t/a in 2022.

As the biggest Paraquat manufacturer in the world, Nanjing Redsun has a Paraquat production capacity of 32,000t/a (converted to 100% Paraquat) with a capacity utilization ratio of 70%-85%. In addition to Paraquat, Nanjing Redsun’s main products include Diquat, Nicotinamide, Chlorpyrifos, Pyridine and its derivatives.

QQ截图20210303155608.pngQQ截图20210303155617.png

Source: Think Real

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox